The panel discussion will be webcast live on the Events and Presentations page under the investor relations section of
About
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.
FOR MORE INFORMATION PLEASE CONTACT: |
|
Media: |
Investors: |
Jane Baj |
Alex Kane |
+1 (908) 912-9167 |
+1 (908) 912-9643 |
View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-evercore-isi-2nd-annual-healthconx-conference-300960397.html
SOURCE